Page 80 - AN-1-2

Advanced Neurology NMDA receptors in neuropsychiatric diseases

modulation of ionotropic glutamate receptors and excitatory NMDA and GluK1-containing kainate receptors. J Med
synaptic transmission. Physiol Res, 57(Suppl 3): S49–S57. Chem, 55: 327–341.
https://doi.org/33549/physiolres.931600 https://doi.org/1021/jm201230z
197. Paoletti P, Neyton J, Ascher P, 1995, Glycine-independent 208. Mullasseril P, Hansen KB, Vance KM, et al., 2010, A subunit-
and subunit-specific potentiation of NMDA responses by selective potentiator of NR2C- and NR2D-containing
extracellular Mg . Neuron, 15: 1109–1120. NMDA receptors. Nat Commun, 1: 90.
2+
https://doi.org/1016/0896-6273(95)90099-3 https://doi.org/1038/ncomms1085
198. Malayev A, Gibbs TT, Farb DH, 2002, Inhibition of the 209. Zhang X, Feng ZJ, Chergui K, 2014, Allosteric modulation
NMDA response by pregnenolone sulphate reveals subtype of GluN2C/GluN2D-containing NMDA receptors
selective modulation of NMDA receptors by sulphated bidirectionally modulates dopamine release: implication for
steroids. Br J Pharmacol, 135: 901–909. Parkinson’s disease. Br J Pharmacol, 171: 3938–3945.
https://doi.org/1038/sj.bjp.0704543 https://doi.org/1111/bph.12758
199. Petrovic M, Sedlacek M, Cais O, et al., 2009, Pregnenolone 210. Wang TM, Brown BM, Deng L, et al., 2017, A novel
sulfate modulation of N-methyl-D-aspartate receptors is NMDA receptor positive allosteric modulator that acts
phosphorylation dependent. Neuroscience, 160: 616–628. via the transmembrane domain. Neuropharmacology,
https://doi.org/1016/j.neuroscience.2009.02.052 121: 204–218.
200. Horak M, Vlcek K, Petrovic M, et al., 2004, Molecular https://doi.org/1016/j.neuropharm.2017.04.041
mechanism of pregnenolone sulfate action at NR1/NR2B 211. Kessels HW, Nabavi S, Malinow R, 2013, Metabotropic
receptors. J Neurosci, 24: 10318–10325. NMDA receptor function is required for beta-amyloid-
https://doi.org/1523/JNEUROSCI.2099-04.2004 induced synaptic depression. Proc Natl Acad Sci U S A,
110: 4033–4038.
201. Bowlby MR, 1993, Pregnenolone sulfate potentiation of
N-methyl-D-aspartate receptor channels in hippocampal https://doi.org/1073/pnas.1219605110
neurons. Mol Pharmacol, 43: 813–819. 212. Ronicke R, Mikhaylova M, Rönicke S, et al., 2011, Early
202. Wong M, Moss RL, 1994, Patch-clamp analysis of direct neuronal dysfunction by amyloid beta oligomers depends
steroidal modulation of glutamate receptor-channels. on activation of NR2B-containing NMDA receptors.
J Neuroendocrinol, 6: 347–355. Neurobiol Aging, 32: 2219–2228.
https://doi.org/1111/j.1365-2826.1994.tb00592.x https://doi.org/1016/j.neurobiolaging.2010.01.011
203. Jang MK, Mierke DF, Russek SJ, et al., 2004, A steroid 213. Li S, Jin M, Koeglsperger T, et al., 2011, Soluble Abeta oligomers
modulatory domain on NR2B controls N-methyl-D- inhibit long-term potentiation through a mechanism
aspartate receptor proton sensitivity. Proc Natl Acad Sci U S involving excessive activation of extrasynaptic NR2B-
A, 101: 8198–8203. containing NMDA receptors. J Neurosci, 31: 6627–6638.
https://doi.org/1073/pnas.0401838101 https://doi.org/1523/JNEUROSCI.0203-11.2011
204. Monaghan DT, Irvine MW, Costa BM, et al., 2012, 214. Hu NW, Klyubin I, Anwyl R, et al., 2009, GluN2B subunit-
Pharmacological modulation of NMDA receptor activity containing NMDA receptor antagonists prevent Abeta-
and the advent of negative and positive allosteric modulators. mediated synaptic plasticity disruption in vivo. Proc Natl
Neurochem Int, 61: 581–592. Acad Sci U S A, 106: 20504–20509.
https://doi.org/1016/j.neuint.2012.01.004 https://doi.org/1073/pnas.0908083106
205. Sapkota K, Irvine MW, Fang G, et al., 2017, Mechanism and 215. Li S, Hong S, Shepardson NE, et al., 2009, Soluble oligomers
properties of positive allosteric modulation of N-methyl-d- of amyloid Beta protein facilitate hippocampal long-term
aspartate receptors by 6-alkyl 2-naphthoic acid derivatives. depression by disrupting neuronal glutamate uptake.
Neuropharmacology, 125: 64–79. Neuron, 62: 788–801.
https://doi.org/1016/j.neuropharm.2017.07.007 https://doi.org/1016/j.neuron.2009.05.012
206. Chopra DA, Sapkota K, Irvine MW, et al., 2017, A single- 216. Ittner LM, Ke YD, Delerue F, et al., 2010, Dendritic function
channel mechanism for pharmacological potentiation of of tau mediates amyloid-beta toxicity in Alzheimer’s disease
GluN1/GluN2A NMDA receptors. Sci Rep, 7: 6933. mouse models. Cell, 142: 387–397.
https://doi.org/1038/s41598-017-07292-8 https://doi.org/1016/j.cell.2010.06.036
207. Irvine MW, Costa BM, Dlaboga D, et al., 2012, Piperazine- 217. Bordji K, Becerril-Ortega J, Nicole O, et al., 2010, Activation
2,3-dicarboxylic acid derivatives as dual antagonists of of extrasynaptic, but not synaptic, NMDA receptors modifies

Volume 1 Issue 2 (2022) 24 https://doi.org/10.36922/an.v1i2.148